Anna Schmitt Selected Research

Anna Schmitt Research Topics

Disease

11	Neoplasms (Cancer) 01/2022 - 11/2016
5	Lymphoma (Lymphomas) 11/2022 - 01/2020
5	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2021 - 03/2014
4	Hodgkin Disease (Hodgkin's Disease) 01/2022 - 01/2019
3	Multiple Myeloma 10/2023 - 01/2019
3	Adenocarcinoma of Lung 11/2017 - 11/2016
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 11/2023 - 01/2019
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2021 - 01/2018
2	Genomic Instability 10/2017 - 01/2015
2	Carcinogenesis 10/2017 - 11/2016
1	Pain (Aches) 01/2023
1	Leukemia 01/2021
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 11/2020
1	Metabolic Diseases (Metabolic Disease) 01/2020
1	Lymphopenia (Lymphocytopenia) 01/2019
1	Febrile Neutropenia 01/2019
1	Vomiting 01/2019
1	Residual Neoplasm 01/2019
1	Lung Neoplasms (Lung Cancer) 01/2018
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2018
1	Adenocarcinoma 10/2017
1	Glioblastoma (Glioblastoma Multiforme) 01/2015
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2011

Drug/Important Bio-Agent (IBA)

5	Phosphotransferases (Kinase)IBA 01/2020 - 01/2017
3	NivolumabIBA 01/2022 - 01/2020
3	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 01/2011
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2020 - 01/2019
3	Imatinib Mesylate (Gleevec)FDA Link 01/2018 - 03/2014
2	Bendamustine Hydrochloride FDA Link 11/2023 - 01/2019
2	Bortezomib (Velcade)FDA Link 11/2023 - 01/2019
2	Dexamethasone (Maxidex)FDA LinkGeneric 11/2023 - 01/2019
2	Rituximab (Mabthera)FDA Link 11/2023 - 01/2019
2	Monoclonal AntibodiesIBA 10/2023 - 01/2020
2	carfilzomibIBA 01/2022 - 01/2019
2	Tyrosine Kinase InhibitorsIBA 01/2021 - 09/2019
2	EnzymesIBA 01/2020 - 01/2019
2	ChromatinIBA 01/2019 - 10/2018
2	Etoposide (VP 16)FDA LinkGeneric 01/2017 - 11/2016
2	Cisplatin (Platino)FDA LinkGeneric 01/2017 - 11/2016
1	Immunoconjugates (Immunoconjugate)IBA 10/2023
1	Proteasome InhibitorsIBA 10/2023
1	belantamab mafodotinIBA 10/2023
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 10/2023
1	Nitrous Oxide (Laughing Gas)IBA 01/2023
1	MeopaIBA 01/2023
1	Analgesics (Analgesic Drugs)IBA 01/2023
1	Oxygen (Dioxygen)IBA 01/2023
1	SolutionsIBA 01/2023
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	tazemetostatIBA 11/2020
1	pembrolizumabIBA 01/2020
1	FluorineIBA 01/2020
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 10/2019
1	Checkpoint Kinase 1IBA 10/2019
1	Melphalan (Alkeran)FDA LinkGeneric 01/2019
1	Prednisone (Sone)FDA LinkGeneric 01/2019
1	AfatinibIBA 11/2018
1	Transcription Factors (Transcription Factor)IBA 10/2018
1	Recombinases (Recombinase)IBA 01/2018
1	venetoclaxIBA 01/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018
1	PoisonsIBA 01/2017
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 01/2017
1	olaparibIBA 01/2017
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2017
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2015
1	Indicators and Reagents (Reagents)IBA 01/2015
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2011

Therapy/Procedure

13	Therapeutics 10/2023 - 03/2014
5	Drug Therapy (Chemotherapy) 01/2022 - 11/2016
4	Stem Cell Transplantation 11/2022 - 01/2011
2	Homologous Transplantation 01/2020 - 01/2011
1	Radiotherapy 11/2022
1	Immunomodulation 01/2020